LAK1 antigen defines two distinct subsets among human tumour infiltrating lymphocytes.

Both lymphokine activated killer (LAK) cells and specific cytotoxic T lymphocytes appear to play a role in tumour immunity. Tumour infiltrating lymphocytes (TIL) which display a CD56+ phenotype (both CD3+ and CD3-) are also likely to possess anti-tumour activity. We have previously described a 120 k...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrarini, M., Ferrero, E., Fortis, C., Poggi, A., Zocchi, M. R.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1990
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971538/
https://www.ncbi.nlm.nih.gov/pubmed/1700922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971538/
https://www.ncbi.nlm.nih.gov/pubmed/1700922

Ejemplares similares